PriceSensitive

Creso Pharma (ASX:CPH) launches three CBD-based teas

Health Care
ASX:CPH
01 April 2021 15:00 (AEST)
Creso Pharma (ASX:CPH) - Co Founder, Boaz Wachtel (left)

Source: ABC

Creso Pharma (CPH) has launched three new CBD-based tea products under its cannaQIX brand.

These products are now available in Switzerland with additional European markets expected in the near-term.

Following a recent decision by the German Federal Court of Justice to reverse charges against hemp tea sellers, Creso will be looking to launch its teas in Germany.

Upon a successful launch of its products in Switzerland and Germany, Creso will aim to expand its reach into other European countries.

These CBD-based teas include cannaQIX tea, cannaQIX NITE tea and cannaQIX Immunity tea.

Source: Creso Pharma

The cannaQIX tea is designed to help the management of stress, the cannaQIX NITE tea is to be consumed at night for a better sleep, while cannaQIX immunity tea optimises well-being.

Creso will use the technology that helped with the manufacturing of these teas for its flagship lozenge products.

“We are proud to have completed the finalisation of this ground-breaking technology for our new CBD tea products, which opens a number of new and globally applicable opportunities for Creso Pharma,” Commercial and Development Director Dr Gian Trepp said.

“The new products and formulation provide a very tasty CBD tea that will become a key component in the future production of the cannaQIX lozenges,” he added.

Creso is up 2.5 per cent on the market and shares are trading at 20.5 cents at 3:17 pm AEDT.

Related News